Recordati Industria Chimica e Farmaceutica S.p.A. is a pharmaceutical company that develops and commercializes medicines for common diseases, rare diseases, and consumer healthcare. The company operates fully integrated functions spanning research and development, chemical and finished product manufacturing, and commercialization. Founded in the 1920s as a family-run pharmacy, the group serves patients globally through its own operations and strategic partnerships. Its business structure covers specialty and primary care sectors, providing treatment options across a diverse portfolio of therapeutic areas.

Summarised from the company's own disclosures, fiscal year ended Dec 2032

Industry Drug Manufacturers - General Homepage recordati.com
Sector Healthcare IR page recordati.com
Tags
rare diseases, specialty care, primary care, consumer healthcare, pharmaceutical manufacturing, research and development
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 23.4%
ROI 23.1%
ROIC 26.7%
Profit margin 16.9%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 12.4%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 81
Quality score 61.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 2.618B 2.342B 2.082B 1.853B 1.58B 1.449B
Net profit 443.624M 416.508M 389.214M 312.336M 385.966M 355.027M
Free cash flow 557.453M 533.271M 455.632M 437.804M 469.798M 382.312M

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024
Balance sheet detail
Trade receivables (EUR) — 269M 308M 362M 445M 517M
↳ YoY growth +14.5% +17.6% +23.0% +16.1%
Other receivables (EUR) — 47.3M 44.9M 63.9M 99.4M 109M
Cash and deposits (EUR) 188M 188M 245M 285M 222M 322M
Intangible assets (EUR) — 1.12B 1.14B 1.76B 1.94B 2.51B
Cash flow detail
Operating cash flow (EUR) — 404M 492M — — —
Purchases of property, plant and equipment (EUR) — -21.3M -21.9M — — —
Purchases of intangible assets (EUR) — -110M -65.5M — — —
Change in receivables (cash effect) (EUR) — -6.03M 43.8M — — —
Change in inventories (cash effect) (EUR) — 42.9M -17.5M — — —
Change in payables (cash effect) (EUR) — 38.6M -46.3M — — —
Dividends paid (cash effect) (EUR) — -213M -217M -117M -123M -130M
Share buybacks (cash effect) (EUR) — -47.9M -102M -52.3M -22.7M -119M
Interest paid (cash effect) (EUR) — -18.7M -18.3M — — —
Income taxes paid (cash effect) (EUR) — 65.3M 91.6M — — —
Share-based compensation (EUR) — 4.88M 5.08M — — —
Operating cash flow before change in receivables (EUR) — 410M 448M — — —
Free cash flow (OCF - PPE - intangibles) (EUR) — 272M 404M — — —
Income detail
Research and development expense (EUR) — 146M 166M — — —
Total comprehensive income (EUR) — 293M 380M 323M 315M 403M
Comprehensive income to owners (EUR) — 293M 380M — — —
Reported Apr 19, 2022 Apr 19, 2022 Apr 19, 2022 Apr 4, 2023 Apr 2, 2024 Sep 24, 2025

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Recordati Industria Chimica e Farmaceutica S.p.A. (ticker REC), listed in Italy.

ETFs Holding Recordati Industria Chimica e Farmaceutica S.p.A.

ETF Weight in ETF Shares Market value As of
ESIM 1.49% 4,529 $ 269.14K Jul 31, 2026
KNO 0.99% 7,673 $ 450.031K Jun 30, 2026
SEIE 0.10% 19,824 $ 1.163M Jun 30, 2026
FENI 0.03% 59,963 $ 3.515M Jun 30, 2026